PIMAVANSERIN SALTS USEFUL FOR THE PRODUCTION OF A PHARMACEUTICAL PREPARATION

The object of the present invention relates to the formula (1) 1-(4-fluorobenzyl)-1-(1- methylpiperidin-4-yl)-3-[4-(2-methylpropoxy)benzyl]carbamide (pimavanserin) besylate, cyclamate, tosylate, benzoate and mandelate salts, as well as to their amorphous and crystalline forms, their hydrates and sol...

Full description

Saved in:
Bibliographic Details
Main Authors VARGA, Zoltán, NAGY, Tamás, RÁCZ, Norbert, MOLNÁRNÉ SAMU, Erika, KÁTAINÉ FADGYAS, Katalin, TÓTHNÉ LAURITZ, Mária, VOLK, Balázs, DIETRICH, Ádám Dezső, KESZTHELYI, Adrienn, SZLÁVIK, László
Format Patent
LanguageEnglish
French
Published 11.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The object of the present invention relates to the formula (1) 1-(4-fluorobenzyl)-1-(1- methylpiperidin-4-yl)-3-[4-(2-methylpropoxy)benzyl]carbamide (pimavanserin) besylate, cyclamate, tosylate, benzoate and mandelate salts, as well as to their amorphous and crystalline forms, their hydrates and solvates, to the production of these salts, and to pharmaceutical preparations containing these, as well as to the therapeutic use of these salts. L'objet de la présente invention porte sur la formule (1) 1- (4-fluorobenzyl)-1-(1-méthylpipéridin-4-yl)-3-[4- (2-méthylpropoxy) benzyl] carbamide (pimavansérine) le bésylate, le cyclamate, le tosylate, le benzoate et les sels de mandelate, ainsi que sur leurs formes amorphes et cristallines, leurs hydrates et leurs solvates, sur la production de ces sels, sur des préparations pharmaceutiques les contenant, ainsi que sur leur utilisation thérapeutique.
Bibliography:Application Number: WO2017HU50027